Licart System
Product Images NDC 71858-0305

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Licart (NDC 71858-0305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Licart 01)

Chemical structure of diclofenac epolamine, showing the diclofenac portion with its dichlorophenyl group and amine linkage, and the epolamine portion represented as 2-(pyrrolidin-1-yl)ethanol.*

FDA Label Image

Figure 1 (Licart 02)

Line graph comparing mean pain levels on a scale from 0 to 100 over 16 treatment days for LICART topical system (.013 g/1 diclofenac epolamine) versus placebo. The graph shows decreasing pain levels with LICART treatment lower than placebo throughout the study period, labeled with protocol 05DCz/FHp11.*

FDA Label Image

Figure 2 (Licart 03)

A line graph depicting mean pain levels on a scale of 0 to 100 over an 8-day treatment period for LICART and placebo groups. The graph shows decreasing pain levels from day 1 to day 8 for both groups, with LICART showing consistently lower pain levels compared to placebo. The graph is titled with protocol number 06EU/FHp03 and includes a legend differentiating LICART and placebo.*

FDA Label Image

Principal Display Panel (15 Patch Carton)

Packaging label for Licart (diclofenac epolamine) topical system 1.3%, a prescription topical system. The box contains 15 topical systems sized 10 cm by 14 cm each and is labeled for once-daily use. The label shows manufacturer IBSA Pharma Inc., with instructions for use and storage included on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.